| Primary |
| Renal Cell Carcinoma |
23.5% |
| Hypertension |
10.6% |
| Metastatic Renal Cell Carcinoma |
10.6% |
| Prostate Cancer |
8.3% |
| Gastrointestinal Stromal Tumour |
6.8% |
| Breast Cancer |
5.0% |
| Prophylaxis |
4.6% |
| Pain |
4.3% |
| Colorectal Cancer |
3.4% |
| Nausea |
2.8% |
| Hepatic Neoplasm Malignant |
2.7% |
| Constipation |
2.6% |
| Diabetes Mellitus |
2.4% |
| Non-small Cell Lung Cancer |
2.3% |
| Renal Cancer |
2.3% |
| Renal Cancer Metastatic |
1.8% |
| Diarrhoea |
1.7% |
| Insomnia |
1.6% |
| Hypothyroidism |
1.5% |
| Dyspepsia |
1.2% |
|
| Death |
9.9% |
| Thrombocytopenia |
8.8% |
| Platelet Count Decreased |
8.7% |
| White Blood Cell Count Decreased |
8.2% |
| Vomiting |
7.7% |
| Pyrexia |
6.3% |
| Pleural Effusion |
6.3% |
| Pneumonia |
5.7% |
| Renal Failure |
5.2% |
| Renal Cell Carcinoma |
4.9% |
| Sepsis |
4.1% |
| Renal Failure Acute |
3.6% |
| Osteonecrosis Of Jaw |
3.4% |
| Myocardial Infarction |
3.3% |
| Syncope |
2.7% |
| General Physical Health Deterioration |
2.6% |
| Pulmonary Embolism |
2.3% |
| Dehydration |
2.1% |
| Ascites |
2.0% |
| Interstitial Lung Disease |
1.9% |
|
| Secondary |
| Renal Cell Carcinoma |
19.7% |
| Metastatic Renal Cell Carcinoma |
9.3% |
| Product Used For Unknown Indication |
8.7% |
| Hypertension |
8.2% |
| Breast Cancer |
7.0% |
| Prophylaxis |
6.9% |
| Gastrointestinal Stromal Tumour |
6.9% |
| Pain |
5.8% |
| Prostate Cancer |
5.5% |
| Colorectal Cancer |
3.7% |
| Constipation |
3.2% |
| Drug Use For Unknown Indication |
3.1% |
| Non-small Cell Lung Cancer |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Renal Cancer |
1.5% |
| Transitional Cell Carcinoma |
1.5% |
| Hypothyroidism |
1.4% |
| Metastatic Gastric Cancer |
1.4% |
| Nausea |
1.3% |
| Hepatic Cirrhosis |
1.3% |
|
| Vomiting |
12.9% |
| Death |
11.6% |
| Renal Cell Carcinoma |
11.4% |
| Pyrexia |
6.1% |
| Sinusitis |
5.5% |
| Malaise |
5.3% |
| Pleural Effusion |
5.3% |
| Osteonecrosis Of Jaw |
4.8% |
| Thrombocytopenia |
4.5% |
| Pulmonary Embolism |
3.8% |
| Neoplasm Malignant |
3.7% |
| Diarrhoea |
3.6% |
| Pneumonia |
3.6% |
| Aortic Dissection |
2.9% |
| Pneumonitis |
2.6% |
| Renal Failure Acute |
2.6% |
| White Blood Cell Count Decreased |
2.6% |
| Hypertension |
2.5% |
| Platelet Count Decreased |
2.5% |
| Pneumonia Bacterial |
2.2% |
|
| Concomitant |
| Metastatic Renal Cell Carcinoma |
62.5% |
| Renal Cell Carcinoma |
10.4% |
| Prophylaxis |
7.0% |
| Metastases To Bone |
2.3% |
| Drug Use For Unknown Indication |
2.0% |
| Hypertension |
1.7% |
| Prostate Cancer |
1.6% |
| Metastases To Thorax |
1.4% |
| Insomnia |
1.3% |
| Renal Cancer |
1.2% |
| Asthenia |
1.0% |
| Diarrhoea |
1.0% |
| Appetite Disorder |
1.0% |
| Oral Candidiasis |
1.0% |
| Anorexia |
0.9% |
| Fatigue |
0.9% |
| Pain |
0.9% |
| Gastrointestinal Stromal Tumour |
0.7% |
| Headache |
0.6% |
| Pyrexia |
0.6% |
|
| Neoplasm Malignant |
12.7% |
| Stomatitis |
10.7% |
| Osteonecrosis Of Jaw |
9.8% |
| Malignant Neoplasm Progression |
7.4% |
| Osteonecrosis |
5.7% |
| Pneumonia Aspiration |
5.7% |
| White Blood Cell Count Decreased |
4.9% |
| C-reactive Protein Increased |
4.1% |
| Neoplasm Progression |
3.7% |
| Platelet Count Decreased |
3.7% |
| Pyrexia |
3.7% |
| Anaemia |
3.3% |
| Haemoglobin Decreased |
3.3% |
| Hyperglycaemia |
3.3% |
| Pneumonia |
3.3% |
| Vomiting |
3.3% |
| Blood Alkaline Phosphatase Increased |
2.9% |
| Blood Lactate Dehydrogenase Increased |
2.9% |
| Death |
2.9% |
| Sepsis |
2.9% |
|
| Interacting |
| Prostate Cancer |
11.4% |
| Product Used For Unknown Indication |
10.1% |
| Breast Cancer |
8.9% |
| Insomnia |
7.6% |
| Depression |
6.3% |
| Metastatic Renal Cell Carcinoma |
6.3% |
| Asthma |
5.1% |
| Headache |
5.1% |
| Hypothyroidism |
5.1% |
| Pneumonia |
5.1% |
| Thrombosis Prophylaxis |
5.1% |
| Gastrointestinal Stromal Tumour |
3.8% |
| Non-small Cell Lung Cancer |
3.8% |
| Renal Cancer |
3.8% |
| Atrial Fibrillation |
2.5% |
| Hypercholesterolaemia |
2.5% |
| Mycosis Fungoides |
2.5% |
| Renal Cell Carcinoma |
2.5% |
| Anxiety |
1.3% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
|
| Renal Failure Acute |
18.2% |
| Ventricular Dysfunction |
13.6% |
| Gingival Bleeding |
9.1% |
| Neutropenia |
9.1% |
| Renal Failure |
9.1% |
| Drug Interaction |
4.5% |
| Epilepsy |
4.5% |
| Hepatic Failure |
4.5% |
| Mental Status Changes |
4.5% |
| Metabolic Acidosis |
4.5% |
| Osteonecrosis Of Jaw |
4.5% |
| Somnolence |
4.5% |
| Thrombocytopenia |
4.5% |
| Vomiting |
4.5% |
|
